KALA BIO, Inc.
KALA
Rank in Stocks
#31253
Kala Bio, Inc. functions as a biopharmaceutical company dedicated to the... Kala Bio, Inc. functions as a biopharmaceutical company dedicated to the creation and commercialization of new therapeutic solutions. The core of their strategy involves utilizing proprietary nanoparticle technology, specifically mucus penetrating particles (MPPs). Initially, their focus for these treatments is directed towards ophthalmic diseases. The company was established in 2009 by co-founders Justin Hanes, Robert S. Langer, and Colin R. Gardner, and its headquarters are located in Arlington, Massachusetts.
Share Price
$0.1773
Last synced: 2026-11-09
Market Cap
$3.43M
Change (1 day)
13.73%
Change (1 year)
-99.52%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade KALA BIO, Inc. (KALA)
Category
Healthcare
EPS for KALA BIO, Inc. (KALA)
EPS as of June 2026 TTM: $-81.82
According to KALA BIO, Inc.'s latest financial reports, its current EPS (TTM) is $-81.82. At the end of 2025 the company had an EPS of $-165.50, an increase over its 2024 EPS of $-507.50.
EPS history for KALA BIO, Inc. from 2013 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-81.82 | -50.56% |
| 2025 | $-165.50 | -67.39% |
| 2024 | $-507.50 | -41.50% |
| 2023 | $-867.50 | -41.15% |
| 2022 | $-1.47K | 1,260.78% |
| 2021 | $-108.32 | 8.86% |
| 2020 | $-99.50 | -27.90% |
| 2019 | $-138.00 | 10.64% |
| 2018 | $-124.73 | 25.74% |
| 2017 | $-99.20 | 3.39% |
| 2016 | $-95.95 | 98.82% |
| 2015 | $-48.26 | 20.56% |
| 2014 | $-40.03 | 81.71% |
| 2013 | $-22.03 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $15.66 | -119.14% |
US
|
|
| $-7.07 | -91.36% |
US
|
|
| $-5.29 | -93.53% |
AU
|
|
| $12.88 | -115.74% |
BE
|
|
| $21.56 | -126.35% |
NL
|
Questions about KALA BIO, Inc.'s earnings per share (EPS)
What is KALA BIO, Inc.'s earnings per share (EPS)?
KALA BIO, Inc.'s earnings per share (EPS) over the last twelve months is $-81.82, as of Jun 2026.
What was KALA BIO, Inc.'s earnings per share (EPS) in 2025?
In 2025, KALA BIO, Inc.'s earnings per share (EPS) was $-165.50, compared with $-507.50 in 2024.
How has KALA BIO, Inc.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, KALA BIO, Inc.'s earnings per share (EPS) was highest in 2020 ($-99.50) and lowest in 2022 ($-1.47K).
How does KALA BIO, Inc.'s earnings per share (EPS) compare with similar companies?
KALA BIO, Inc.'s earnings per share (EPS) ($-81.82) is lower than that of all 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.